FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jill Slansky

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Jill E Slansky; J John Cohen; John C Cambier
Integrated immunology in Colorado.
Tullia C Bruno; Jena D French; Bryan R Haugen; Kimberly R Jordan; Martin D McCarter; Oscar Ramirez; Trisha R Sippel; Virginia F Borges; Allen Waziri; Jill E Slansky
Influence of human immune cells on cancer: studies at the University of Colorado.
Jonathan D Buhrman; Jill E Slansky
Improving T cell responses to modified peptides in tumor vaccines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jill Slansky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jill E Slansky; J John Cohen; John C Cambier
Integrated immunology in Colorado.
Immunologic research 2013;55(1-3):1-2.
2013: Tullia C Bruno; Jena D French; Bryan R Haugen; Kimberly R Jordan; Martin D McCarter; Oscar Ramirez; Trisha R Sippel; Virginia F Borges; Allen Waziri; Jill E Slansky
Influence of human immune cells on cancer: studies at the University of Colorado.
Immunologic research 2013;55(1-3):22-33.
2013: Jonathan D Buhrman; Jill E Slansky
Improving T cell responses to modified peptides in tumor vaccines.
Immunologic research 2013;55(1-3):34-47.
2013: Jonathan D Buhrman; Kimberly R Jordan; Charles B Kemmler; Jonathan Sprague; Lance U'ren; Jill E Slansky
Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.
Cancer research 2013;73(1):74-85.
2012: Kimberly R Jordan; John W Kappler; Brandon L Moore; Jonathan D Buhrman; Dexiang Gao; Jonathan Sprague; Jill E Slansky
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
Cancer immunology, immunotherapy : CII 2012;61(10):1627-38.
2012: L Mitchell; Jill E Slansky; S W Dow; B J Biller
Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma.
Veterinary immunology and immunopathology 2012;145(3-4):597-603.
2011: Charles B Kemmler; Eric T Clambey; Ross M Kedl; Jill E Slansky
Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(9):4431-9.
2010: Kimberly R Jordan; Rachel H McMahan; Charles B Kemmler; John W Kappler; Jill E Slansky
Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(10):4652-7.
2010: Beth A Tamburini; Tzu L Phang; Susan P Fosmire; Milcah C Scott; Susan C Trapp; Megan M Duckett; Sally R Robinson; Jill E Slansky; Leslie C Sharkey; Gary R Cutter; John Wojcieszyn; Donald Bellgrau; Robert M Gemmill; Lawrence E Hunter; Jaime F Modiano
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma.
BMC cancer 2010;10():619.
2010: Jill E Slansky; Kimberly R Jordan
The Goldilocks model for TCR-too much attraction might not be best for vaccine design.
PLoS biology 2010;8(9):.
2009: Kimberly R Jordan; Fran Crawford; John W Kappler; Jill E Slansky
Vaccination of mice with baculovirus-infected insect cells expressing antigenic proteins.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2009;Chapter 2():Unit 2.15.
2008: Jennifer A McWilliams; Richard T Sullivan; Kimberly R Jordan; Rachel H McMahan; Charles B Kemmler; Marcia McDuffie; Jill E Slansky
Age-dependent tolerance to an endogenous tumor-associated antigen.
Vaccine 2008;26(15):1863-73.
2008: Kimberly R Jordan; Rachel H McMahan; Jason Z Oh; Matthew R Pipeling; Drew M Pardoll; Ross M Kedl; John W Kappler; Jill E Slansky
Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(1):188-97.
2007: Kiyoshi Yoshimura; Lindsay S Laird; Christina Y Chia; Kristen F Meckel; Jill E Slansky; John M Thompson; Ajay Jain; Drew M Pardoll; Richard D Schulick
Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells.
Cancer research 2007;67(20):10058-66.
2007: Rachel H McMahan; Jill E Slansky
Mobilizing the low-avidity T cell repertoire to kill tumors.
Seminars in cancer biology 2007;17(4):317-29.
2006: Rachel H McMahan; Jennifer A McWilliams; Kimberly R Jordan; Steven W Dow; Darcy B Wilson; Jill E Slansky
Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.
The Journal of clinical investigation 2006;116(9):2543-51.
2006: Jennifer A McWilliams; Sean M McGurran; Steven W Dow; Jill E Slansky; Ross M Kedl
A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(1):155-61.
2006: Frances Crawford; Kimberly R Jordan; Brian Stadinski; Yibing Wang; Eric S Huseby; Philippa Marrack; Jill E Slansky; John W Kappler
Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands.
Immunological reviews 2006;210():156-70.
2006: Kiyoshi Yoshimura; Ajay Jain; Heather E Allen; Lindsay S Laird; Christina Y Chia; TANNA RAVI; Dirk G Brockstedt; Martin A Giedlin; Keith Bahjat; Meredith L Leong; Jill E Slansky; David N Cook; Thomas W Dubensky; Drew M Pardoll; Richard D Schulick
Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.
Cancer research 2006;66(2):1096-104.
2003: Jill E Slansky
Antigen-specific T cells: analyses of the needles in the haystack.
PLoS biology 2003;1(3):E78.
2003: Ajay Jain; Jill E Slansky; Laurel C Matey; Heather E Allen; Drew M Pardoll; Richard D Schulick
Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases.
Annals of surgical oncology 2003;10(7):810-20.
2003: Anne M Ercolini; Jean-Pascal H Machiels; Yi Cheng Chen; Jill E Slansky; Martin Giedlen; Richard T. Reilly; Elizabeth M Jaffee
Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(8):4273-80.
2003: Leo Luznik; Jill E Slansky; Sanju Jalla; Ivan Borrello; Hyam I Levitsky; Drew M Pardoll; Ephraim J Fuchs
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras.
Blood 2003;101(4):1645-52.
2001: SM O'Herrin; Jill E Slansky; Q Tang; Mary A. Markiewicz; Thomas F Gajewski; Drew M Pardoll; Jonathan P Schneck; Jeffrey A Bluestone
Antigen-specific blockade of T cells in vivo using dimeric MHC peptide.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(5):2555-60.
2001: Jonathan P Schneck; Jill E Slansky; SM O'Herrin; T F Greten
Monitoring antigen-specific T cells using MHC-Ig dimers.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 17():Unit 17.2.
2001: S Y Tseng; Mizuto Otsuji; Kevin Gorski; Xin Huang; Jill E Slansky; Sara I Pai; A Shalabi; Tae Kwang Shin; Drew M Pardoll; Haruo Tsuchiya
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
The Journal of experimental medicine 2001;193(7):839-46.
2000: Jill E Slansky; FM Rattis; L F Boyd; Tarek M Fahmy; Elizabeth M Jaffee; Jonathan P Schneck; David Margulies; Drew M Pardoll
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.
Immunity 2000;13(4):529-38.
1998: Tim F Greten; Jill E Slansky; Ryuji Kubota; Samantha S Soldan; Elizabeth M Jaffee; Thomas P Leist; Drew M Pardoll; Steven Jacobson; Jonathan P Schneck
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7568-73.
1998: Kaja Murali-Krishna; John D Altman; M Suresh; David J D Sourdive; AJ Zajac; Joseph D Miller; Jill E Slansky; Rafi Ahmed
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
Immunity 1998;8(2):177-87.
1997: CJ Fry; Jill E Slansky; Peggy J Farnham
Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain.
Molecular and cellular biology 1997;17(4):1966-76.
1996: Jill E Slansky; Peggy J Farnham
Transcriptional regulation of the dihydrofolate reductase gene.
BioEssays : news and reviews in molecular, cellular and developmental biology 1996;18(1):55-62.
1996: Jill E Slansky; Peggy J Farnham
Introduction to the E2F family: protein structure and gene regulation.
Current topics in microbiology and immunology 1996;208():1-30.
1994: Y Li; Jill E Slansky; D J Myers; Norman R Drinkwater; William G Kaelin; Peggy J Farnham
Cloning, chromosomal location, and characterization of mouse E2F1.
Molecular and cellular biology 1994;14(3):1861-9.
1993: Peggy J Farnham; Jill E Slansky; R Kollmar
The role of E2F in the mammalian cell cycle.
Biochimica et biophysica acta 1993;1155(2):125-31.
1993: Jill E Slansky; Y Li; William G Kaelin; Peggy J Farnham
A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter.
Molecular and cellular biology 1993;13(3):1610-8.
1992: A L Means; Jill E Slansky; S L McMahon; M W Knuth; Peggy J Farnham
The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter.
Molecular and cellular biology 1992;12(3):1054-63.